MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bayer Ag ADR (OP:BAYRY)

10.55 +10.55 (+1054900.00%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bayer Ag ADR

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
What's Going On With BridgeBio Pharma Stock On Monday? ↗
BridgeBio Pharma partners with Bayer on acoramidis for ATTR-CM in Europe. $310 million deal, FDA application accepted. 
Via Benzinga
News headline image
BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out? ↗
BridgeBio will receive a tiered royalty on sales that begins at the low-30% range. 
Via Investor's Business Daily
News headline image
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too? ↗
On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks. 
Via InvestorPlace
News headline image
3 Overextended Stocks That Need to Slash Their Dividends ASAP ↗
The most common attribute of overextended stocks other than carrying too much debt is dividends that are too big. 
Via InvestorPlace
News headline image
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential ↗
MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months. 
Via Talk Markets
News headline image
Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million ↗
I-Mab will become a completely US-based company, divesting itself of I-Mab Biopharma (Hangzhou), an unconsolidated affiliate. I-Mab Hangzhou will acquire rights to I-Mab’s drug assets in Greater China... 
Via Talk Markets
News headline image
Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial ↗
Follow the landmark Australian Roundup lawsuit against Bayer. Closing arguments in class action alleging Roundup's link to cancer. 
Via Benzinga
Topics Lawsuit
News headline image
Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout ↗
"Bayer's Monsanto ordered to pay $2.2 billion in Roundup cancer case. Explore the landmark verdict, compensatory losses, and punitive damages. 
Via Benzinga
News headline image
Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week ↗
Shanghai Argo Biopharma entered 2 agreements with Novartis, out-licensing four next-gen RNAi therapeutics for $185 million upfront and a total value of $4.2 billion. Additionally, Ambrx Biopharma will... 
Via Talk Markets
News headline image
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance ↗
Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positioning themselves to tap into the  
Via Benzinga
News headline image
Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial ↗
Monday, Bayer AG (OTC: BAYRY (OTC: BAYZF)  
Via Benzinga
News headline image
Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial ↗
Bayer completed an 18-month data collection in the Phase Ib trial for a gene therapy for treating patients with Parkinson's. 
Via Benzinga
News headline image
Top Stocks, Sectors Loved By Congress Members Who Traded In 2023: Apple, NVIDIA, Microsoft, Ford And More Stocks To Watch In 2024 ↗
One of the hottest topics among members of Congress and investors has been the stock and options trading activity by several politicians. 
Via Benzinga
News headline image
Best 4 Agriculture Companies For Your 2024 Investment Portfolio ↗
Agriculture is and remains, a crucial sector for sustaining life, offering investors diverse opportunities in this vital industry. 
Via Talk Markets
News headline image
Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak ↗
In a significant turn of events, Bayer AG (OTC: BAYRY) (OTC: BAYZF) emerged victorious in a California lawsuit filed by Bruce Jones, who alleged that the use of Roundup caused his non-Hodgkin... 
Via Benzinga
Topics Lawsuit
News headline image
ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US ↗
With climate change becoming a mega market force, ESG investing is rising. The XVV is up 28% YTD. Agri-Tech stocks like Bayer AG, FMC Corporation, and Corteva Inc are providing climate resilience... 
Via Benzinga
Topics Climate Change
News headline image
AI Meets Biotech: 3 Top Stocks Transforming Medical Science ↗
The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss ↗
Bayer AG (OTC: BAYRY) (OTC:  
Via Benzinga
News headline image
Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion ↗
The spotlight is on a Philadelphia trial as Bayer AG (OTC: BAYRY) (OTC: BAYZF) grapples with mounting legal challenges surrounding its Roundup weedkiller, prompted by multi-billion dollar verdicts  
Via Benzinga
Topics Lawsuit
News headline image
PFAS's Forever Problem: Ohio Lawsuit Against Chemical Companies Fizzles Out ↗
Big chemical companies won a lawsuit preventing 11.8 million Ohio residents from suing them for PFAS chemicals in their blood. 
Via Benzinga
Topics Lawsuit
News headline image
3 Battered Blue-Chip Stocks to Sell in December ↗
Steer clear of these once flourishing companies, each of which has problems they need to overcome before their share price rises again. 
Via InvestorPlace
News headline image
German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks ↗
Bayer AG (OTC: BAYRY) (OTC: BAYZF) reportedly held an investor call to address concerns after intense scrutiny from investors following a series of unforeseen setbacks, prompting questions about... 
Via Benzinga
News headline image
Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence ↗
Monday, Bayer AG (OTC: BAYRY) (OTC: BAYZF)  
Via Benzinga
News headline image
Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details ↗
Bayer AG (OTC: BAYRY) (OTC: BAYZF)  
Via Benzinga
News headline image
Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits ↗
The Delaware Supreme Court reportedly ruled in favor of Bayer AG (OTC: BAYRY) (OTC: BAYZF), stating that the company is not accountable for lawsuits associated with talc-based foot powder products... 
Via Benzinga
Topics Lawsuit
News headline image
Bayer CEO Resists Full Tri-Split, German Conglomerate Cuts Management Jobs In The Face Of Q3 Loss ↗
Bayer AG (OTC: BAYRY) (OTC: BAYZF) CEO Bill Anderson announced  
Via Benzinga
News headline image
Earnings Review: Bayer To Make Strategic Changes After Q3 Results ↗
The latest financial statements from Bayer Group show a year-over-year decline in several key areas, painting a stark picture of the company’s fiscal health. 
Via Talk Markets
News headline image
Legal Woes Mount for Bayer As Roundup Weed Killer-Related Cancer Cases Continue, Faces Third Trial Loss ↗
Bayer AG (OTC: BAYRY) (OTC:  
Via Benzinga
News headline image
Cathie Wood’s Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving ↗
Investors tend to closely watch which Cathie Wood stocks are bought and sold as she has history of generating big returns in her ETFs 
Via InvestorPlace
News headline image
AI To Revolutionize Clinical Trials And Diagnostics ↗
With the help of technology, the pharmaceutical industry is gaining new insights that are fueling the development of next generation of drugs while also speeding up clinical trials and improving... 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story